Tomopenem is a novel 1␤-methylcarbapenem with a broad spectrum of activity against clinically important gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (5) . ␤-Lactams are known to bind to penicillin-binding proteins (PBPs) that function in peptidoglycan biosynthesis (16) . The PBP profiles of carbapenems are consistent with their broadspectrum activity. Moreover, their actions with certain PBPs govern the morphological changes in bacteria seen in the presence of carbapenems (2, 14) . Alteration of PBPs, about which there are few reports (12) for Enterobacteriaceae and P. aeruginosa, is one of the mechanisms of carbapenem resistance. However, concern about the emergence of carbapenem resistance is growing (4) . Therefore, we determined the affinity of tomopenem for PBPs in S. aureus, Escherichia coli, and P. aeruginosa, the morphological changes, and the potential for tomopenem resistance.
Membrane fractions from S. aureus ATCC 6538P, E. coli NIHJ, and P. aeruginosa ATCC 15692 were prepared as described previously (15) . The drug's affinity for PBPs in S. aureus and E. coli was assayed by [ 14 C]benzylpenicillin (Amersham Pharmacia Biotech UK Limited) (13) . After contact with the gels, the imaging plate (Fuji Photo Film Co., Ltd.) was subjected to imaging analysis with a Bio-Imaging analyzer (model BAS 2000; Fuji Photo Film Co., Ltd.). The drug's affinity for PBPs in P. aeruginosa was assayed by Bocillin FL (Invitrogen Corporation) (17) . Labeled PBPs were visualized by using a molecular imager FX Pro (Bio-Rad Laboratories, Inc.) and quantified by using Quantity One software (version 4.5; BioRad Laboratories, Inc.). The 50% inhibitory concentrations (IC 50 s) were calculated. The MICs and minimum bactericidal concentrations (MBCs) were measured by the standard microdilution method (10, 11) . The observation of E. coli and P. aeruginosa morphology was performed by growing cultures in cation-adjusted Mueller-Hinton broth (CAMHB) and then adding tomopenem at 1/8, 1, and 8 times the MIC. After fixation, the cells were observed with a scanning electron microscope (model S-4000; Hitachi Ltd.) at a magnification of ϫ10,000. Spontaneous mutants of three pathogens were selected by plating overnight cultures harvested by centrifugation onto Mueller-Hinton agar containing carbapenems at 2, 4, and 8 times the MIC. Development of resistance in S. aureus and P. aeruginosa was assessed by the broth dilution method. Three independent colonies were suspended in CAMHB and CAMHB containing 0.4% (wt/vol) potassium nitrate, to give a final concentration of 5 ϫ 10 5 CFU/ml. After incubation in a broth containing twofold serial dilutions of carbapenems, a test tube in which colonies had grown to more than 50% of the density of the control was selected for each subsequent passage.
Tomopenem had high affinities for PBPs 1, 2, and 4 but not for PBP 3 in S. aureus ( Table 1 ). The IC 50 of tomopenem for PBP 2 was fourfold higher than that of imipenem (IPM) and was similar to that of meropenem (MEM), while the MIC of tomopenem was eightfold higher than that of IPM and was similar to that of MEM. The IC 50 s of carbapenems tested for PBP 2 seemed to be correlated with their MICs. In our previous report (6) , the IC 50 s of tomopenem for PBP 2a in two strains of MRSA were 14-to 25-fold higher than that for PBP 2, which might indicate the MICs (MIC 50 and MIC 90 ) of tomopenem against methicillin-sensitive S. aureus (0.12 and 0.12 g/ml) and MRSA (4 and 8 g/ml) (5). In E. coli, tomopenem had the highest affinity for PBP 2, as did MEM and IPM, but IPM had low affinity for PBP 3. The IC 50 of tomopenem for PBP 2 was threefold lower than that of IPM and was similar to that of MEM, while the MIC of tomopenem was eightfold lower than that of IPM and was similar to that of MEM. Since the synergistic inhibition of both PBP 2 and 3 was the main In P. aeruginosa, tomopenem had as high an affinity for PBP 2 as it did for PBP 3. The antibacterial activity of ␤-lactams is governed by the integration of the PBP affinities, the permeability of the outer membrane, the stability of ␤-lactamase, and the substrate extrusion rate in gram-negative bacteria. There were slight differences in the stability of ␤-lactamase in P. aeruginosa in response to tomopenem, IPM, and MEM (9), and the antibacterial activity of tomopenem against a MexABOprM-overproducing strain had less influence than that of MEM (6) . Although the rate of penetration of tomopenem was not examined, the higher affinity of tomopenem for PBPs 2 and 3 compared to that of IPM and its lower recognition of efflux pumps compared to that of MEM are the main mechanisms of its better antibacterial activity. Morphologically, in E. coli, tomopenem induced a swollen form (Fig. 1b) at 1/8 times the MIC and spherical and bulge formations (Fig. 1d) at 8 times the MIC. In P. aeruginosa, tomopenem induced filamentation (Fig. 1f ) at 1/8 times the MIC and a bulge formation (Fig. 1g) at the MIC. These primary morphological responses would be in good agreement with the drug's highest affinity for PBP 2 (sphere formation) in E. coli and would be due to its simultaneously binding to PBP 2 and PBP 3 (filamentation) in P. aeruginosa.
The frequencies of spontaneous resistance of S. aureus and P. aeruginosa to tomopenem were comparable to those to IPM or MEM ( Table 2 ). The frequencies of resistance of E. coli to tomopenem and IPM were higher than that to MEM. The profiles of the susceptibility of the mutants obtained with tomopenem against S. aureus (SRR2a), E. coli (ERR2a, ERR2b, and ERR4a), and P. aeruginosa (PRR4a) showed cross-resistance to IPM and MEM, IPM, and IPM, MEM, and levofloxacin, respectively ( Table 3 ). The reason why the frequency of spontaneous resistance of E. coli to tomopenem was higher than that to MEM is unclear, but resistance to IPM might be related to the cross-resistance to IPM against the mutants as shown by the other carbapenems. In P. aeruginosa, there is a possibility that we selected MexAB-OprM-overproducing OprD-deficient double mutants as reported previously (8), although the mechanisms of resistance were not determined.
The subculturing of S. aureus and P. aeruginosa in tomopenem led to a twofold and an eightfold decrease in susceptibility after 10 passages, respectively (Fig. 2) . Since periods of extensive IPM use are associated with significant increases in resistance (3, 7) , the preservation of the activity of tomopenem would require appropriate use. aeruginosa was cultured in a medium containing tomopenem (F), imipenem (OE), and meropenem (f) for 18 h at 35°C. Shown are representative results with S. aureus and P. aeruginosa, since the development of resistance in all three colonies showed almost the same result with both species.
In conclusion, the PBP profiles of carbapenems tested in these pathogens were correlated with their antibacterial activities. The morphological changes induced by tomopenem corresponded to the PBP binding data. The PBP profiles of tomopenem, with potent binding to multiple essential PBPs in S. aureus, E. coli, and P. aeruginosa, are related to the broadspectrum activities against gram-positive and gram-negative bacteria.
